Company Filing History:
Years Active: 2023
Title: Steven Philp - Innovator in Bromodomain Inhibitor Synthesis
Introduction
Steven Philp is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of chemical synthesis, particularly in the development of bromodomain inhibitors. His work is characterized by innovative processes that enhance the purity and scalability of chemical compounds.
Latest Patents
Steven Philp holds a patent for a "Process for the preparation of bromodomain inhibitor." This invention provides processes for the synthesis and purification of a bromodomain inhibitor, referred to as Compound 1. The patent includes various forms of the compound, such as crystalline forms, amorphous forms, solvates, and hydrates. The disclosed methods offer scalable chemical synthesis routes that yield a highly pure final product. Additionally, the patent outlines techniques to isolate the most stable polymorph of Compound 1 through crystallization from formic acid and water.
Career Highlights
Steven Philp is associated with Celgene Quanticel Research, Inc., where he applies his expertise in chemical synthesis. His innovative approaches have contributed to advancements in the pharmaceutical industry, particularly in the development of therapeutic agents.
Collaborations
Steven has collaborated with notable colleagues, including John Fitzgerald Traverse and Kelvin Hin-Yeong Yong. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Steven Philp's contributions to the field of chemical synthesis, particularly in bromodomain inhibitors, highlight his innovative spirit and dedication to advancing pharmaceutical research. His work continues to impact the industry positively.